Taro Pharmaceutical Industries shares owned by Tower Research Capital
Quarter-by-quarter ownership of Taro Pharmaceutical Industries (TARO) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Taro Pharmaceutical Industries
Tip: Access up to 7 years of quarterly data
All positions including Taro Pharmaceutical Industries held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Taro Pharmaceutical Industries by Tower Research Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $5.0k | 119 | 42.34 |
2023-09-30 | $12k | 309 | 37.67 |
2023-06-30 | $39k | 1.0k | 37.93 |
2023-03-31 | $0 | 17 | 0.00 |
2022-09-30 | $3.0k | 107 | 28.04 |
2022-06-30 | $5.0k | 140 | 35.71 |
2022-03-31 | $0 | 4 | 0.00 |
2021-12-31 | $2.0k | 35 | 57.14 |
2021-09-30 | $0 | 5 | 0.00 |
2021-06-30 | $174k | 2.4k | 71.79 |
2021-03-31 | $128k | 1.7k | 73.77 |
2020-12-31 | $23k | 312 | 73.72 |
2020-09-30 | $21k | 389 | 53.98 |
2020-06-30 | $13k | 194 | 67.31 |
2020-03-31 | $15k | 240 | 62.50 |
2019-12-31 | $165k | 2.0k | 83.33 |
2019-09-30 | $7.0k | 97 | 72.16 |
2019-06-30 | $324k | 3.8k | 85.01 |
2019-03-31 | $70k | 634 | 110.29 |
2018-12-31 | $687k | 8.1k | 84.57 |
2018-09-30 | $146k | 1.5k | 98.19 |
2018-06-30 | $208k | 1.8k | 115.61 |
2018-03-31 | $548k | 5.5k | 98.71 |
2017-12-31 | $314k | 3.0k | 104.69 |
2017-09-30 | $122k | 1.1k | 112.75 |
2017-03-31 | $259k | 2.2k | 116.48 |
2016-12-31 | $2.0k | 20 | 100.00 |
2016-09-30 | $17k | 162 | 107.44 |
2016-06-30 | $51k | 282 | 181.82 |
2016-03-31 | $21k | 145 | 144.83 |
2015-09-30 | $5.0k | 35 | 142.86 |
2015-06-30 | $2.0k | 12 | 166.67 |
2013-12-31 | $57k | 576 | 98.96 |
2013-09-30 | $8.0k | 100 | 80.00 |
2013-06-30 | $21k | 382 | 54.97 |
More positions owned by Tower Research Capital
Home Depot (HD)
View all positions for Tower Research Capital
Top funds holding Taro Pharmaceutical Industries
View all funds holding Taro Pharmaceutical Industries